NIH Funding Opportunities (RSS Feed)

Notice of Change of Receipt Date for RFA-HL-21-016 "HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)"

October 21, 2020

Notice NOT-HL-20-822 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Notice of Change of Receipt Date for RFA-HL-21-015 "HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)"

October 21, 2020

Notice NOT-HL-20-821 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

NIH Operates Under a Continuing Resolution

October 21, 2020

Notice NOT-OD-21-009 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Pre-Application Webinar for RFA-CA-20-049, New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) and RFA-CA-20-050, CEECR Coordinating Center (U24 Clinical Trial Not Allowed)

October 21, 2020

Notice NOT-CA-21-006 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

October 21, 2020

Funding Opportunity PA-21-051 from the NIH Guide for Grants and Contracts. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidates dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

For more information, visit the Sponsor URL.

BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)

October 21, 2020

Funding Opportunity RFA-MH-21-140 from the NIH Guide for Grants and Contracts. Reissue of RFA-MH-19-148. This Funding Opportunity Announcement (FOA) intends to accelerate the integration and use of scalable technologies and tools to enhance brain cell census research, including the development of technology platforms and/or resources that will enable a swift and comprehensive survey of brain cell types and circuits. Applications are expected to address limitations and gaps of existing technologies/tools as a benchmark against which the improvements or competitive advantages of the proposed ones will be measured. The improvements include throughput, sensitivity, selectivity, scalability, spatiotemporal resolution and reproducibility in cell census analyses. The projects funded under this FOA will align with the overarching goals of the BRAIN Initiative Cell Census Network (BICCN) and are expected to enable the generation of a substantial amount of cell census data using the proposed technologies or via collaboration with the BICCN.

For more information, visit the Sponsor URL.

Notice of Change to RFA-OD-19-028

October 21, 2020

Notice NOT-OD-21-017 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.

New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)

October 20, 2020

Funding Opportunity RFA-AI-20-076 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research on the development and validation of innovative strategies to deliver anti-HIV gene therapies efficiently to specific target cells in vivo.

For more information, visit the Sponsor URL.

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)

October 20, 2020

Funding Opportunity PAR-21-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.

For more information, visit the Sponsor URL.

Notice to Extend the Response Date for NOT-LM-20-015, "Request for Information (RFI): Strategic Opportunities and Challenges for the National Library of Medicine, National Institutes of Health".

October 20, 2020

Notice NOT-LM-21-002 from the NIH Guide for Grants and Contracts

For more information, visit the Sponsor URL.